Bioluminescent monitoring of NIS-mediated 131i ablative effects in MCF-7 xenografts

Molecular Imaging

Volumn 5, Issue 2, 2006, Pages 76-84

  Ghosh, Malavika ^a   Gambhir, Sanjiv Sam ^a   De, Abhijit ^a   Nowels, Kent ^a   Goris, Michael ^a   Wapnir, Irene ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Department of Surgery ^*  (United States)

Author keywords

Bioluminescence; Breast cancer; Luciferase; NIS; Radioabalation; Sodium iodide symporter

Indexed keywords

BREAST CANCER; LUCIFERASE; NIS; RADIOABALATION; SODIUM IODIDE SYMPORTER;

BIOLUMINESCENCE; CELL CULTURE; ENZYME KINETICS; GENE TRANSFER; GROWTH KINETICS; IMPLANTS (SURGICAL); RADIATION EFFECTS; TUMORS;

MEDICAL IMAGING;

COTRANSPORTER; PHOTOPROTEIN; RADIOACTIVE IODINE; SODIUM IODIDE SYMPORTER;

ANIMAL; ARTICLE; BIOSYNTHESIS; CANCER TRANSPLANTATION; CELL CLONE; EXPERIMENTAL NEOPLASM; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LUMINESCENCE; METABOLISM; MOUSE; NUDE MOUSE; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE; XENOGRAFT;

ANIMALS; CELL LINE, TUMOR; CLONE CELLS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IODINE RADIOISOTOPES; LUMINESCENT MEASUREMENTS; LUMINESCENT PROTEINS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; SYMPORTERS; TRANSPLANTATION, HETEROLOGOUS;

EID: 33746282802     PISSN: 15353508     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fcr.2006.03.004     Document Type: Article

References (32)

1. Schlumberger M, Tubiana M, De Vathaire F, Hill C, Gardet P, Travagli JP, Fragu P, Lumbroso J, Caillou B, Parmentier C (1986). Long-term results of treatment of 283 patients with lung and bone metastases from differentiated thyroid carcinoma. J Clin Endocrinol Metab. 63:960-967.
2. Schlumberger MJ (1998). Papillary and follicular thyroid carcinoma. N Engl J Med 338:297-306.
3. Mazzaferri E (2000). Radioiodine and other treatment and outcomes. In LE Braverman, & RD Utiger (Eds.), Werner and Ingbar's the thyroid: A fundamental and clinical text (pp. 904-929). Philadelphia: JB Lippincott.
4. Dai G, Levy O, Carrasco N (1996). Cloning and characterization of the thyroid iodide transporter. Nature, 379:458-460.
5. Tazebay UH, Wapnir IL, Levy O, Dohan O, Zuckier LS, Zhao QH, Deng H. F, Amenta PS, Fineberg S, Pestell RG, Carrasco N (2000). The mammary gland iodide transporter is expressed during lactation and in breast cancer. Nat Med. 6:871-878.
6. Wapnir IL, van de Rljn M, Nowels K, Amenta PS, Walton K, Montgomery K, Greco RS, Dohan O, Carrasco N (2003). Immunohistochemical profile of the sodium/iodide symporter in thyroid, breast, and other carcinomas using high density tissue microarrays and conventional sections. J Clin Endocrinol Metab. 88:1880-1888.
7. Kim YH, Lee DS, Kang JH, Lee YJ, Chung JK, Roh JK, Kim SU, Lee MC (2005). Reversing the silencing of reporter sodium/iodide symporter transgene for stem cell tracking. J Nucl Med. 46:305-311.
8. Lee KH, Kim HK, Paik JY, Matsui T, Choe YS, Choi Y, Kim BT (2005). Accuracy of myocardial sodium/iodide symporter gene expression imaging with radioiodide: Evaluation with a dual-gene adenovirus vector. J Nucl Med. 46:652-657.
9. So MK, Kang JH, Chung JK, Lee YJ, Shin JH, Kim KI, Jeong JM, Lee DS, Lee MC (2004). In vivo imaging of retinoic acid receptor activity using a sodium/iodide symporter and luciferase dual imaging reporter gene. Mol Imaging. 3:163-171.
10. Shin JH, Chung JK, Kang JH, Lee YJ, Kim KI, So Y, Jeong JM, Lee DS, Lee MC (2004). Noninvasive imaging for monitoring of viable cancer cells using a dual-imaging reporter gene. J Nucl Med. 45:2109-2115.
11. Mandell RB, Mandell LZ, Link CJ Jr (1999). Radioisotope concentrator gene therapy using the sodium/iodide symporter gene. Cancer Res. 59:661-668.
12. Cho JY, Xing S, Liu X, Buckwalter TL, Hwa L, Sferra TJ, Chiu IM, Jhiang SM (2000). Expression and activity of human Na+/I- symporter in human glioma cells by adenovirus-mediated gene delivery. Gene Ther. 7:740-749.
13. Cho JY, Shen DH, Yang W, Williams B, Buckwalter TL, La Perle KM, Hinkle G, Pozderac R, Kloos R, Nagaraja HN, Barth RF, Jhiang SM (2002). In vivo imaging and radioiodine therapy following sodium iodide symporter gene transfer in animal model of intracerebral gliomas. Gene Ther. 9:1139-1145.
14. Spitzweg C, Joba W, Eisenmenger W, Heufelder AE (1998). Analysis of human sodium iodide symporter gene expression in extrathyroidal tissues and cloning of its complementary deoxyribonucleic acids from salivary gland, mammary gland, and gastric mucosa. J Clin Endocrinol Metab. 83:1746-1751.
15. Moon DH, Lee SJ, Park KY, Park KK, Ahn SH, Pai MS, Chang H, Lee HK, Ahn IM (2001). Correlation between 99mTc-pertechnetate uptakes and expressions of human sodium iodide symporter gene in breast tumor tissues. Nucl Med Biol. 28:829-834.
16. Wapnir IL, Goris M, Yudd A, Dohan O, Adelman D, Nowels K, Carrasco N (2004). The Na+/I- symporter mediates iodide uptake in breast cancer metastases and can be selectively down-regulated in the thyroid. Clin Cancer Res. 10:4294-4302.
17. Gudkov AV, Komarova EA (2003). The role of p53 in determining sensitivity to radiotherapy. Nat Rev Cancer. 3:117-129.
18. Xia F, Powell SN (2002). The molecular basis of radiosensitivity and chemosensitivity in the treatment of breast cancer. Semin Radiat Oncol. 12:296-304.
19. Stassen T, Port M, Nuyken I, Abend M (2003). Radiation-induced gene expression in MCF-7 cells. Int J Radiat Biol. 79:319-331.
20. Contag CH, Jenkins D, Contag PR, Negrin RS (2000). Use of reporter genes for optical measurements of neoplastic disease in vivo. Neoplasia. 2:41-52.
21. Edinger M, Cao YA, Hornig YS, Jenkins DE, Verneris MR, Bachmann MH, Negrin RS, Contag CH (2002). Advancing animal models of neoplasia through in vivo bioluminescence imaging. Eur J Cancer. 38:2128-2136.
22. de Wet JR, Wood KV, Helinski DR, DeLuca M (1985). Cloning of firefly luciferase cDNA and the expression of active luciferase in Escherichia coli. Proc Natl Acad Sci USA. 82:7870-7873.
23. Lu Y, Dang H, Middleton B, Zhang Z, Washburn L, Campbell-Thompson M, Atkinson MA, Gambhir SS, Tian J, Kaufman DL (2004). Bioluminescent monitoring of islet graft survival after transplantation. Mol Ther. 9:428-435.
24. Zhang L, Hellstrom KE, Chen L (1994). Luciferase activity as a marker of tumor burden and as an indicator of tumor response to antineoplastic therapy in vivo. Clin Exp Metastasis. 12:87-92.
25. De A, Lewis XZ, Gambhir SS (2003). Noninvasive imaging of lentiviral-mediated reporter gene expression in living mice. Mol Ther. 7:681-691.
26. Wapnir IL, Wartenberg DE, Greco RS (1996). Three-dimensional staging of breast cancer. Breast Cancer Res Treat. 41:15-19.
27. Schlumberger M, Challeton C, De Vathaire F, Parmentier C (1995). Treatment of distant metastases of differentiated thyroid carcinoma. J Endocrinol Invest. 18:170-172.
28. 131I) in patients with papillary and follicular thyroid cancer and the issue of remnant ablation: A consensus report. Eur J Endocrinol. 153:651-659.
29. Spitzweg C, O'Connor MK, Bergert ER, Tindall DJ, Young CY, Morris JC (2000). Treatment of prostate cancer by radioiodine therapy after tissue-specific expression of the sodium iodide symporter. Cancer Res. 60:6526-6530.
30. Boland A, Ricard M, Opolon P, Bidart JM, Yeh P, Filetti S, Schlumberger M, Perricaudet M (2000). Adenovirus-mediated transfer of the thyroid sodium/iodide symporter gene into tumors for a targeted radiotherapy. Cancer Res. 60:3484-3492.
31. Spitzweg C, Dietz AB, O'Connor MK, Bergert ER, Tindall DJ, Young CY, Morris JC (2001). In vivo sodium iodide symporter gene therapy of prostate cancer. Gene Ther. 8:1524-1531.
32. Scholz IV, Cengic N, Baker CH, Harrington KJ, Maletz K, Bergert ER, Vile R, Goke B, Morris JC, Spitzweg C (2005). Radioiodine therapy of colon cancer following tissue-specific sodium iodide symporter gene transfer. Gene Ther. 12:272-280.